Skip to content

Clinical evaluation of traditional Chinese medicine in the prevention and treatment of emerging epidemics based on data sharing platform

Clinical evaluation of traditional Chinese medicine in the prevention and treatment of emerging epidemics based on data sharing platform

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084466
Enrollment
Unknown
Registered
2024-05-17
Start date
2024-05-20
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, influenza A, human infection with highly pathogenic avian influenza, dengue fever and pertussis

Interventions

Retrospective observation cohort:None
Prospective observation cohort:None

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with COVID-19, influenza A, highly pathogenic avian influenza, dengue fever and pertussis

Exclusion criteria

Exclusion criteria: Those who were deemed unfit to participate in this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Diagnosis and treatment plan;Effective rate of treatment;

Secondary

MeasureTime frame
demographic data ;underlying disease;

Countries

China

Contacts

Public ContactSong Rui

Beijing Ditan Hospital, Capital Medical University

13126595640@163.com+86 131 2659 5640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026